Citation Impact
Citing Papers
Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits
1988
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects
1978
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
2018
Genetic factors affecting blood lipoproteins: the candidate gene approach.
1988
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Serum lipid response to a fat-modified, oatmeal-enhanced diet
1988
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
1997
Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study
1997
Placebo‐controlled Trial of the Effects of Guar Gum and Metformin on Fasting Blood Glucose and Serum Lipids in Obese, Type 2 Diabetic Patients
1990
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Role of Uncoupling Protein-2 Up-Regulation and Triglyceride Accumulation in Impaired Glucose-Stimulated Insulin Secretion in a β-Cell Lipotoxicity Model Overexpressing Sterol Regulatory Element-Binding Protein-1c
2004
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Prospects for Cardiovascular Research
2001 StandoutNobel
Cholesterol-lowering effects of dietary fiber: a meta-analysis
1999 Standout
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1994
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 Standout
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
1997
The changing landscape of atherosclerosis
2021 StandoutNature
Lipid profiles after the daily consumption of an oat-based cereal: a controlled crossover trial
1994
Metabolic origins and clinical significance of LDL heterogeneity
2002
Unravelling the familial tendency to aneurysmal disease: Popliteal aneurysm, hypertension and fibrillin genotype
1996
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
1994
Bile acid sequestrants
2011
Correlation of Quality Measures With Estimates of Treatment Effect in Meta-analyses of Randomized Controlled Trials
2002
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men
2001
Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events
2001
Soluble fiber and serum lipids: A literature review
1994
meta-analysis bias in location and selection of studies
1998
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain
1988
Insulin resistance and cardiovascular disease
2000
Triglycerides and cardiovascular disease
2014
Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography
1990
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production
2004
Might treatment of hypercholesterolaemia increase non-cardiac mortality?
1991
Measuring inconsistency in meta-analyses
2003 Standout
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
1991
The contribution of thrombosis to the clinical expression of coronary atherosclerosis
1996
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
2005
Lipid-lowering interventions in angiographic trials
1995
Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene
1996
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-lliac atherosclerosis
1989
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
1992
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials
1995
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
1995
Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies
1992
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
In VivoEvidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus1
2001
Guar gum and gemfibrozil — an effective combination in the treatment of hypercholesterolaemia
1989
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
2003 Standout
Atherosclerosis
2000 StandoutNature
Treatment Goals for Low-Density Lipoprotein Cholesterol in the Secondary Prevention of Coronary Heart Disease: Absolute Levels or Extent of Lowering?
1997
Sequestration of aggregated low-density lipoproteins by macrophages
2002
Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease
1999
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men
1992
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Comparison of the Effects of Oat Bran and Low-Fiber Wheat on Serum Lipoprotein Levels and Blood Pressure
1990
Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population
2018
Lipoprotein lipase in diabetes
1987
TREATMENT OF HYPERLIPIDAEMIA RETARDS PROGRESSION OF SYMPTOMATIC FEMORAL ATHEROSCLEROSIS A Randomised Controlled Trial
1983
Report of the Conference on Low Blood Cholesterol: Mortality Associations.
1992
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
1992 StandoutScience
Plasma triglyceride and coronary heart disease.
1991
TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE")
1977
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Type III Hyperlipoproteinemia: Defective Metabolism of an Abnormal Apolipoprotein E
1981 Science
The National Cholesterol Education Program
1989 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol
1984
Transfers and exchanges of esterified cholesterol between plasma lipoproteins
1982
Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men
1992
Women, work and coronary heart disease: prospective findings from the Framingham heart study.
1980
Triglycerides and the Risk of Coronary Heart Disease
2006
In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism.
1979
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts
1978
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
1995 StandoutNobel
Influence of gemfibrozil on high-density lipoproteins
1983
Prevalence of Intermittent Claudication and Its Effect on Mortality
1982
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
1980
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype.
1992
Population-Based Frequency of Dyslipidemia Syndromes in Coronary-Prone Families in Utah
1990
Pharmacological and surgical treatment of obesity.
2004
Atherogenesis: a postprandial phenomenon.
1979 Standout
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2004 Standout
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: Comparison with endogenous hypertriglyceridemia
1978
Evidence that two synthetic pathways contribute to the apolipoprotein B pool of the low density lipoprotein fraction of rabbit plasma
1982
The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia
1982
A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts
1992
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.
1992
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.
1988
Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia effects of plasma exchange
1979
The uptake of the apoprotein and cholesteryl ester of high-density lipoproteins by the perfused rat liver
1987
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Kuopio Atherosclerosis Prevention Study (KAPS)
1995
Scoping studies: towards a methodological framework
2005 Standout
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies
1996 Standout
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
1982 StandoutNobel
Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia
1977
Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months
1982
Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects
1985
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
1979 Standout
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
1995
Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men.
1992
Epidemiology of Atherosclerotic Peripheral Arterial Occlusive Disease in Hong Kong
1999
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Cardiovascular Disease Mortality in Familial Forms of Hypertriglyceridemia: A 20-Year Prospective Study
2000
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
1994
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Genetic Dissection of Complex Traits
1994 StandoutScience
Cessation of Smoking in Patients with Intermittent Claudication
1987
Cholesterol Turnover in Man
1970
Reduction in Cardiovascular Events During Pravastatin Therapy
1995
Differentiation of avian keratinocytes. Characterization and relations of the keratin proteins of adult and embryonic feathers and scales
1972
The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
1988
Lipoprotein apoprotein metabolism.
1978
Direct Visualization of Lipid Deposition and Reverse Lipid Transport in a Perfused Artery
2000
Catabolism of Very Low Density Lipoprotein B Apoprotein in Man
1978
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
1992
Recent progress in understanding apolipoprotein B.
1990
Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man
1984
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Serum lipid response to oat product intake with a fat-modified diet
1986
The degradation of very low density lipoprotein by the extrahepatic tissues of the rat
1978
Diet and plasma lipids—a reappraisal
1978
SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
1978
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
1984
Assessment of long-term plasma exchange for familial hypercholesterolaemia.
1980
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease.
1991
Absorption and Metabolism of Dietary Cholesterol
1983
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Clinical, Haemodynamic, Rheological, and Biochemical Findings in 126 Patients with Intermittent Claudication
1973
A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction
1996
Hypocholesterolemic Effects of Different Bulk-Forming Hydrophilic Fibers as Adjuncts to Dietary Therapy in Mild to Moderate Hypercholesterolemia
1991
Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits.
1982
Human Aging: Usual and Successful
1987 StandoutScience
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Intermediate filaments as mechanical integrators of cellular space
1980 StandoutNature
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
1987
Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study.
1994
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
2013
Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII.
1984
Works of B. Lewis being referenced
Lipoproteins, atherosclerosis, and coronary heart disease
1981
Serum Lipoprotein Abnormalities in Patients with Ischaemic Heart Disease: Comparisons with a Control Population
1974
Modified plasma-derived lipoproteins in human atherosclerotic plaques
1988
Metabolic studies on the hypolipidaemic effect of guar gum
1990
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: The Caerphilly and Speedwell Collaborative Heart Disease Studies
1992
The Value of Lowering Cholesterol after Myocardial Infarction
1990
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)
1993
On lowering lipids in the post‐infarction patient
1991
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
1992
Gemfibrozil in the Treatment of Resistant Familial Hypercholesterolemia and Type III Hyperlipoproteinaemia
1988
Lipoprotein fractionation by a precipitation method. a simple quantitative procedure
1976
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
1974
Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia
1985
Metabolism of Very Low Density Lipoproteins in Hyperlipidaemia: Studies of Apolipoprotein B Kinetics in Man
1976
Coronary Heart Disease: Reducing the Risk
1999
SERUM LIPIDS AND LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
1971
Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.
1991
Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemia
1980
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
Hereditary hyperlipidemia and atherosclerosis in the rabbit due to overproduction of lipoproteins. II. Preliminary report of arterial pathology.
1987
COMPOSITION OF PLASMA CHOLESTEROL ESTER IN RELATION TO CORONARY-ARTERY DISEASE AND DIETARY FAT
1958
Relationship between changes in plasma lipoprotein concentrations and fecal steroid excretion in man during consumption of four experimental diets
1985
The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia
1982
Randomised Controlled Trial of the Treatment of Hyperlipidaemia on Progression of Atherosclerosis
1985
Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.
1992
Reduction of serum triglyceride levels by polyunsaturated fat Studies on the mode of action and on very low density lipoprotein composition
1974
The Evaluation of Lipoprotein Changes During Gemfibrozil Treatment
1976
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion
1981
The Amino Acid Composition of Certain Morphologically Distinct Parts of White Turkey Feathers, and of Goose Feather Barbs and Goose Down
1955
Splanchnic Metabolism of Plasma Apolipoprotein B
1981
High-Density Lipoprotein Metabolism
1980
Modes of action of lipid‐lowering diets in man: studies of apolipoprotein B kinetics in relation to fat consumption and dietary fatty acid composition
1983
Heritability of the Low Density Lipoprotein Receptor Activity of Human Blood Mononuclear Cells: Studies in Normolipidaemic Adult Male Twins
1982
Estimation of the rate of breakdown of cholesterol in man by measurement of 14CO-2 excretion after intravenous [26-14C]cholesterol.
1966
Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man
1980
TOWARDS AN IMPROVED LIPID-LOWERING DIET: ADDITIVE EFFECTS OF CHANGES IN NUTRIENT INTAKE
1981
Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I. Biochemical studies.
1987
Lipokinetic Studies with Gemfibrozil (CI-719)
1976
Lipoprotein concentrations in serum and in biopsy samples of arterial intima A quantitative comparison
1976
An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro
1985
Flux of plasma lipoproteins into human arterial intima Comparison between grossly normal and atheromatous intima
1981
Studies of the mechanisms of carbohydrate-induced lipaemia in normal man
1973
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo
1995
Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjects
1980
The Modernization of Asia
1996
Plasma Triglyceride and Fatty Acid Metabolism in Diabetes mellitus
1972
Individual Variation in the Effects of Dietary Cholesterol on Plasma Lipoproteins and Cellular Cholesterol Homeostasis in Man
1981
Relationships between the metabolism of high‐density and very‐low‐density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity
1982